Drug recall · June 1, 2022
Zonisamide Capsules USP recall
Why: CGMP Deviations: Gaps in the quality system in the Quality Control microbiology laboratory.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Zonisamide Capsules USP, 100 mg, 90-count bottle, Rx Only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 61919-775-90
- Lots / codes
Lot: 23JY2124 Exp. 6/30/23
- Quantity
- 16 bottles
- Company
- Direct Rx, Dawsonville, GA
- Distribution
- Nationwide to the U.S. market
- Initiated
- May 13, 2022 · Voluntary: Firm initiated
- Classified
- May 20, 2022
- Reported
- June 1, 2022
- Ended
- September 30, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Zonisamide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.